Martin Marino
Fortuna: 380 032 $ al 31/05/2026
Fortuna: 380 032 $ al 31/05/2026
Mr. Martin A. Marino is a Chief Executive Officer & Director at Aluvis International, Inc. and an Independent Chairman at Microbix Biosystems, Inc. He is on the Board of Directors at Aluvis International, Inc. and Blue-Zone Technologies Ltd. Mr. Marino was previously employed as a General Counsel by Merck KGaA.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MICROBIX BIOSYSTEMS INC. 1,44 % | 28/05/2026 | 2.000.167 ( 1,44 % ) | 380 032 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Presidente | 15/10/2020 |
Blue-Zone Technologies Ltd.
Blue-Zone Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Provides anesthetic collection and recovery services | Director/Miembro de la Junta | - |
Aluvis International, Inc.
Aluvis International, Inc. Information Technology ServicesTechnology Services Offers UV clean technology solutions for healthcare industry | Director Ejecutivo | 01/05/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| MERCK KGAA | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Microbix Biosystems, Inc.
Microbix Biosystems, Inc. BiotechnologyHealth Technology Develops biological products and technologies | Health Technology |
Blue-Zone Technologies Ltd.
Blue-Zone Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Provides anesthetic collection and recovery services | Commercial Services |
Aluvis International, Inc.
Aluvis International, Inc. Information Technology ServicesTechnology Services Offers UV clean technology solutions for healthcare industry | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.